132 related articles for article (PubMed ID: 38049556)
21. Surgical treatment of breast cancer in Norway 2003-2018.
Skjerven HK; Danielsen AS; Schlichting E; Sahlberg KK; Hofvind S
Tidsskr Nor Laegeforen; 2020 Oct; 140(15):. PubMed ID: 33118768
[TBL] [Abstract][Full Text] [Related]
22. Long-term prognosis of breast cancer detected by mammography screening or other methods.
Lehtimäki T; Lundin M; Linder N; Sihto H; Holli K; Turpeenniemi-Hujanen T; Kataja V; Isola J; Joensuu H; Lundin J
Breast Cancer Res; 2011; 13(6):R134. PubMed ID: 22204661
[TBL] [Abstract][Full Text] [Related]
23. Comparisons of assessment pathways after abnormal mammography screening in Denmark, Norway, and Spain.
Jørgensen SF; Sagstad S; Louro J; Román M; Castells X; Hofvind S; Njor S
Breast Cancer Res Treat; 2024 May; 205(1):135-145. PubMed ID: 38285110
[TBL] [Abstract][Full Text] [Related]
24. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.
Nederend J; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; Louwman MW
Breast Cancer Res; 2012 Jan; 14(1):R10. PubMed ID: 22230363
[TBL] [Abstract][Full Text] [Related]
25. BreastScreen-based mammography screening in women with a personal history of breast cancer, Western Australian study.
Houssami N; Tresham JJ; Fritschi L; Wylie LE
Med J Aust; 2011 Oct; 195(8):460-4. PubMed ID: 22004397
[TBL] [Abstract][Full Text] [Related]
26. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.
Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA
Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459
[TBL] [Abstract][Full Text] [Related]
27. Asymptomatic breast cancer in non-participants of the national screening programme in Norway: a confounding factor in evaluation?
Hoff SR; Klepp O; Hofvind S
J Med Screen; 2012 Dec; 19(4):177-83. PubMed ID: 23486698
[TBL] [Abstract][Full Text] [Related]
28. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
29. Self-reported symptoms among participants in a population-based screening program.
Larsen M; Lilleborge M; Vigeland E; Hofvind S
Breast; 2020 Dec; 54():56-61. PubMed ID: 32927237
[TBL] [Abstract][Full Text] [Related]
30. Screening outcomes by risk factor and age: evidence from BreastScreen WA for discussions of risk-stratified population screening.
Noguchi N; Marinovich ML; Wylie EJ; Lund HG; Houssami N
Med J Aust; 2021 Oct; 215(8):359-365. PubMed ID: 34374095
[TBL] [Abstract][Full Text] [Related]
31. Digital compared to screen-film mammography: breast cancer prognostic features in an organized screening program.
Prummel MV; Done SJ; Muradali D; Majpruz V; Brown P; Jiang H; Shumak RS; Yaffe MJ; Holloway CM; Chiarelli AM
Breast Cancer Res Treat; 2014 Sep; 147(2):389-99. PubMed ID: 25108740
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological differences between interval and screen-detected breast cancers diagnosed within a screening programme in Northern Portugal.
José Bento M; Gonçalves G; Aguiar A; Antunes L; Veloso V; Rodrigues V
J Med Screen; 2014 Jun; 21(2):104-9. PubMed ID: 24803482
[TBL] [Abstract][Full Text] [Related]
33. Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program.
Møller P; Stormorken A; Jonsrud C; Holmen MM; Hagen AI; Clark N; Vabø A; Sun P; Narod SA; Mæhle L
Breast Cancer Res Treat; 2013 May; 139(1):155-61. PubMed ID: 23615785
[TBL] [Abstract][Full Text] [Related]
34. Interval Breast Cancer Rates and Histopathologic Tumor Characteristics after False-Positive Findings at Mammography in a Population-based Screening Program.
Hofvind S; Sagstad S; Sebuødegård S; Chen Y; Roman M; Lee CI
Radiology; 2018 Apr; 287(1):58-67. PubMed ID: 29239711
[TBL] [Abstract][Full Text] [Related]
35. Early detection of breast cancer through population-based mammographic screening in Asian women: a comparison study between screen-detected and symptomatic breast cancers.
Chuwa EW; Yeo AW; Koong HN; Wong CY; Yong WS; Tan PH; Ho JT; Wong JS; Ho GH
Breast J; 2009; 15(2):133-9. PubMed ID: 19292798
[TBL] [Abstract][Full Text] [Related]
36. Breast screening and breast cancer survival in Aboriginal and Torres Strait Islander women of Australia.
Roder D; Webster F; Zorbas H; Sinclair S
Asian Pac J Cancer Prev; 2012; 13(1):147-55. PubMed ID: 22502658
[TBL] [Abstract][Full Text] [Related]
37. Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers.
Defossez G; Quillet A; Ingrand P
BMC Cancer; 2018 Apr; 18(1):393. PubMed ID: 29625602
[TBL] [Abstract][Full Text] [Related]
38. Evidence from a BreastScreen cohort does not support a longer inter-screen interval in women who have no conventional risk factors for breast cancer.
Noguchi N; Marinovich ML; Wylie EJ; Lund HG; Houssami N
Breast; 2022 Apr; 62():16-21. PubMed ID: 35114637
[TBL] [Abstract][Full Text] [Related]
39. Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density.
Conant EF; Barlow WE; Herschorn SD; Weaver DL; Beaber EF; Tosteson ANA; Haas JS; Lowry KP; Stout NK; Trentham-Dietz A; diFlorio-Alexander RM; Li CI; Schnall MD; Onega T; Sprague BL;
JAMA Oncol; 2019 May; 5(5):635-642. PubMed ID: 30816931
[TBL] [Abstract][Full Text] [Related]
40. Long-term risk of screen-detected and interval breast cancer after false-positive results at mammography screening: joint analysis of three national cohorts.
Román M; Hofvind S; von Euler-Chelpin M; Castells X
Br J Cancer; 2019 Jan; 120(2):269-275. PubMed ID: 30563993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
